Drug profile · INN
insulin detemir
LEVEMIR FLEXPEN
insulin detemir (LEVEMIR FLEXPEN) is a insulin receptor agonist. Associated with NovoThirteen. Route of administration: injection. Current US regulatory status: approved.
Drug details — insulin detemir
- US status
- approved
- Class
- Alimentary tract and metabolism (A10)
- Route
- INJECTION
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
insulin detemir (LEVEMIR FLEXPEN) is a insulin receptor agonist. Associated with NovoThirteen. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Insulin receptor agonist
Primary target: Insulin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is insulin detemir?
insulin detemir (LEVEMIR FLEXPEN) is a insulin receptor agonist. Associated with NovoThirteen. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for insulin detemir?
LEVEMIR FLEXPEN is a marketed brand name for insulin detemir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin detemir?
insulin detemir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.